Cite
HARVARD Citation
Nadaraja, S. et al. (2020). ARAP1 is an independent prognostic biomarker in older women with ovarian high-grade serous adenocarcinoma receiving first-line platinum-based antineoplastic therapy. Acta oncologica. pp. 40-47. [Online].